此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Mechanisms Underlying Postoperative Insulin Resistance and Inflammation

2012年10月4日 更新者:University of Nottingham

Investigating Whether the Magnitude of Postoperative Inflammatory and Insulin Resistant Responses is Related to Body Composition and Physiological Function of Skeletal Muscle & Adipose Tissue

Having an operation places an enormous burden on the body, leading to the development of inflammation and so called 'insulin resistance'. Insulin resistance means the body is unable to respond to important hormones that control use of energy. Recent studies have shown that patients who develop 'higher' insulin resistance and inflammation have more serious complications and take longer to recover after surgery. The investigators do not know what controls the development of insulin resistance and inflammation after surgery. Similarly, the investigators do not know why certain patients develop much more insulin resistance and inflammation than others, even though they have the same operation.

The main purpose of the study is to try to find out which patients are prone to developing greater 'amounts' of insulin resistance and inflammation. The investigators also want to find out whether the investigators can reduce the 'amount' of insulin resistance and inflammation in these patients (for example by giving them carbohydrate [sugar-based] drinks before surgery - these have been shown to reduce insulin resistance in some patient groups).

Information from this study should improve the way the investigators prepare patients before surgery and this should help to improve patient outcomes following surgery (by reducing complications and speeding recovery after major surgery).

研究概览

详细说明

Interested participants who are undergoing abdominal (tummy) surgery will be recruited from surgical clinics. They will be asked to attend the Greenfield Human Physiology Laboratory where they will be asked to complete two questionnaires. In addition, a sample of blood, and a small sample of muscle and fat from their thigh will be taken. They will undergo a low dose X-ray (DXA scan) and an insulin clamp. The insulin clamp involves being connected to an insulin and glucose drip for around four hours during which their blood pressure and pulse is monitored and regular blood samples are taken.

Participants will be allocated randomly to one of two groups. One group will receive a carbohydrate (sugar) drink before surgery and the other group will receive a dummy (placebo) drink.

On the day of surgery, pre-operative checks and assessment will proceed as normal. After the participant is asleep under anaesthetic, a blood sample and tummy muscle and fat samples will be taken by the surgeon through the surgical incision. At the end of surgery, another blood sample and muscle and fat samples from the tummy and thigh will be taken while the participant is still under anaesthetic.

On the day after surgery, a further blood test and tummy and thigh muscle and fat sample will be taken. Participants will also undergo another insulin clamp.

The research team will follow participants' progress after surgery, but the decision to allow them home will be made by the medical team responsible for their care.

研究类型

介入性

注册 (预期的)

32

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age 18-75 yrs
  • Correct BMI and waist circumference criteria : Obese group - BMI ≥30 AND waist circumference ≥94 cm in men and ≥ 80 cm in women, Non obese group - BMI 18.5-25 AND waist circumference ≤94cm in men and ≤80 cm in women Due to undergo elective major abdominal surgery ASA I-III Caucasian patients Able to give informed consent and comply with study protocol

Exclusion Criteria:

  • History of significant preoperative weight loss (>10% over preceding 3 weeks)

    • Clinical history of pulmonary aspiration
    • Known gastro-oesophageal reflux disease (GORD) or hiatus hernia
    • History of difficult intubation or conditions leading to the latter such as: previous neck radiotherapy/rheumatoid arthritis/presence of thyroid goitre
    • Metabolic disorders (e.g. diabetes mellitus, thyroid disease, Cushing's Syndrome)
    • Simultaneous participation in another clinical study or involvement in a clinical study within the preceding 3 months,
    • Patients with suspicion of alcohol/drug abuse
    • Pregnancy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:肥胖
carbohydrate drink
Open muscle biopsy
Venopuncture
实验性的:Normal body weight
carbohydrate drink
Open muscle biopsy
Venopuncture
安慰剂比较:Normal Body Weight placebo
Participants of mormal body weight given placebo
Open muscle biopsy
Venopuncture
安慰剂比较:Obese placebo
Participants who are obese given placebo
Open muscle biopsy
Venopuncture

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Within subject differences in perioperative insulin sensitivity (M-value, corrected for insulin concentrations) amongst obese, non-obese, carbohydrate loaded and non-carbohydrate loaded patients.
大体时间:2 weeks
2 weeks

次要结果测量

结果测量
大体时间
Correlation between body composition and changes in perioperative insulin sensitivity
大体时间:2 weeks
2 weeks
Differences in inflammatory cytokine gene expression
大体时间:2 months
2 months
Differences in muscle and fat genes and proteins controlling carbohydrate/fat oxidation and insulin signalling
大体时间:3 months
3 months
Differences activities of muscle and fat enzymes involved in carbohydrate/fat/carnitine metabolism
大体时间:2 months
2 months
Differences in the aforementioned between peripheral and central fat and muscle
大体时间:2 months
2 months
The incidence of post-operative infectious and non-infectious complications
大体时间:30 days
30 days
Length of hospital stay (difference between groups)
大体时间:6 weeks
6 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2011年11月1日

初级完成 (预期的)

2012年11月1日

研究完成 (预期的)

2012年11月1日

研究注册日期

首次提交

2011年11月9日

首先提交符合 QC 标准的

2011年11月10日

首次发布 (估计)

2011年11月11日

研究记录更新

最后更新发布 (估计)

2012年10月5日

上次提交的符合 QC 标准的更新

2012年10月4日

最后验证

2012年10月1日

更多信息

与本研究相关的术语

其他研究编号

  • 11040 (DAIDS ES Registry Number)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅